Lower neutrophil-to-lymphocyte ratio predicts high risk of multidrug-resistant Pseudomonas aeruginosa infection in patients with hospital-acquired pneumonia

Yu-Qi Zhou,1,2,* Ding-Yun Feng,1,2,* Wen-Juan Li,1,2 Hai-Ling Yang,1,2 Zhao-Ni Wang,3 Tian-Tuo Zhang,1,2 Zhuang-Gui Chen1,3 1Institute of Respiratory Diseases of Sun Yat-Sen University, Guangzhou, Guangdong, China; 2Department of Internal Medicine, Division of Respiratory Diseases, Guangzhou, Guang...

Full description

Bibliographic Details
Main Authors: Zhou YQ, Feng DY, Li WJ, Yang HL, Wang ZN, Zhang TT, Chen ZG
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Online Access:https://www.dovepress.com/lower-neutrophil-to-lymphocyte-ratio-predicts-high-risk-of-multidrug-r-peer-reviewed-article-TCRM
_version_ 1818723165367435264
author Zhou YQ
Feng DY
Li WJ
Yang HL
Wang ZN
Zhang TT
Chen ZG
author_facet Zhou YQ
Feng DY
Li WJ
Yang HL
Wang ZN
Zhang TT
Chen ZG
author_sort Zhou YQ
collection DOAJ
description Yu-Qi Zhou,1,2,* Ding-Yun Feng,1,2,* Wen-Juan Li,1,2 Hai-Ling Yang,1,2 Zhao-Ni Wang,3 Tian-Tuo Zhang,1,2 Zhuang-Gui Chen1,3 1Institute of Respiratory Diseases of Sun Yat-Sen University, Guangzhou, Guangdong, China; 2Department of Internal Medicine, Division of Respiratory Diseases, Guangzhou, Guangdong, China; 3Department of Pediatrics, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China *These authors contributed equally to this work Background and purpose: Hospital-acquired pneumonia (HAP) remains an important cause of morbidity and mortality despite advances in antimicrobial therapy. The emergence of multidrug resistant (MDR) Pseudomonas aeruginosa (PA) is of major concern. Our aim was to evaluate the risk factors and prognosis of HAP due to MDR-PA infection.Patients and methods: In a retrospective observational study, we collected data on all episodes of HAP caused by PA (PA-HAP) occurring from January 2013 to December 2016. Characteristics of patients with drug-sensitive PA were compared with those with MDR-PA. Data of demographic, underlying conditions, peripheral neutrophil-to-lymphocyte ratio (NLR), and clinical outcomes were collected and analyzed.Results: One hundred fifty-seven patients with PA-HAP were included, of which 69 (43.9%) patients were diagnosed with MDR-PA infection. There were significant differences between MDR-PA group and non-MDR-PA group on the following variables: initial inappropriate antibiotic therapy (P<0.001, OR 0.103, 95% CI 0.044–0.244), admission in more than two departments in previous 30 days (P<0.001, OR 0.186, 95% CI 0.072–0.476), and NLR level (P=0.020, OR 0.911, 95% CI 0.843–0.985). The effect of antibiotic treatment was significantly different (P<0.001, OR 4.263, 95% CI 2.142–8.483). The 30-day mortality was higher in MDR-PA group than that in non-MDR-PA group (P<0.001).Conclusion: We have shown that lower NLR level was identified as a clinical predictor of MDR-PA infection in HAP patients. Even with goal-directed therapy, MDR-PA infection implicates poor outcomes in patients with HPA. Keywords: risk factors, prognosis, multidrug-resistant Pseudomonas aeruginosa, hospital-acquired pneumonia
first_indexed 2024-12-17T21:06:11Z
format Article
id doaj.art-501327ae50a645099c52cb344c08ea59
institution Directory Open Access Journal
issn 1178-203X
language English
last_indexed 2024-12-17T21:06:11Z
publishDate 2018-10-01
publisher Dove Medical Press
record_format Article
series Therapeutics and Clinical Risk Management
spelling doaj.art-501327ae50a645099c52cb344c08ea592022-12-21T21:32:34ZengDove Medical PressTherapeutics and Clinical Risk Management1178-203X2018-10-01Volume 141863186941063Lower neutrophil-to-lymphocyte ratio predicts high risk of multidrug-resistant Pseudomonas aeruginosa infection in patients with hospital-acquired pneumoniaZhou YQFeng DYLi WJYang HLWang ZNZhang TTChen ZGYu-Qi Zhou,1,2,* Ding-Yun Feng,1,2,* Wen-Juan Li,1,2 Hai-Ling Yang,1,2 Zhao-Ni Wang,3 Tian-Tuo Zhang,1,2 Zhuang-Gui Chen1,3 1Institute of Respiratory Diseases of Sun Yat-Sen University, Guangzhou, Guangdong, China; 2Department of Internal Medicine, Division of Respiratory Diseases, Guangzhou, Guangdong, China; 3Department of Pediatrics, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China *These authors contributed equally to this work Background and purpose: Hospital-acquired pneumonia (HAP) remains an important cause of morbidity and mortality despite advances in antimicrobial therapy. The emergence of multidrug resistant (MDR) Pseudomonas aeruginosa (PA) is of major concern. Our aim was to evaluate the risk factors and prognosis of HAP due to MDR-PA infection.Patients and methods: In a retrospective observational study, we collected data on all episodes of HAP caused by PA (PA-HAP) occurring from January 2013 to December 2016. Characteristics of patients with drug-sensitive PA were compared with those with MDR-PA. Data of demographic, underlying conditions, peripheral neutrophil-to-lymphocyte ratio (NLR), and clinical outcomes were collected and analyzed.Results: One hundred fifty-seven patients with PA-HAP were included, of which 69 (43.9%) patients were diagnosed with MDR-PA infection. There were significant differences between MDR-PA group and non-MDR-PA group on the following variables: initial inappropriate antibiotic therapy (P<0.001, OR 0.103, 95% CI 0.044–0.244), admission in more than two departments in previous 30 days (P<0.001, OR 0.186, 95% CI 0.072–0.476), and NLR level (P=0.020, OR 0.911, 95% CI 0.843–0.985). The effect of antibiotic treatment was significantly different (P<0.001, OR 4.263, 95% CI 2.142–8.483). The 30-day mortality was higher in MDR-PA group than that in non-MDR-PA group (P<0.001).Conclusion: We have shown that lower NLR level was identified as a clinical predictor of MDR-PA infection in HAP patients. Even with goal-directed therapy, MDR-PA infection implicates poor outcomes in patients with HPA. Keywords: risk factors, prognosis, multidrug-resistant Pseudomonas aeruginosa, hospital-acquired pneumoniahttps://www.dovepress.com/lower-neutrophil-to-lymphocyte-ratio-predicts-high-risk-of-multidrug-r-peer-reviewed-article-TCRMrisk factorsprognosismultidrug-resistant pseudomonas aeruginosahospital-acquired pneumonia
spellingShingle Zhou YQ
Feng DY
Li WJ
Yang HL
Wang ZN
Zhang TT
Chen ZG
Lower neutrophil-to-lymphocyte ratio predicts high risk of multidrug-resistant Pseudomonas aeruginosa infection in patients with hospital-acquired pneumonia
Therapeutics and Clinical Risk Management
risk factors
prognosis
multidrug-resistant pseudomonas aeruginosa
hospital-acquired pneumonia
title Lower neutrophil-to-lymphocyte ratio predicts high risk of multidrug-resistant Pseudomonas aeruginosa infection in patients with hospital-acquired pneumonia
title_full Lower neutrophil-to-lymphocyte ratio predicts high risk of multidrug-resistant Pseudomonas aeruginosa infection in patients with hospital-acquired pneumonia
title_fullStr Lower neutrophil-to-lymphocyte ratio predicts high risk of multidrug-resistant Pseudomonas aeruginosa infection in patients with hospital-acquired pneumonia
title_full_unstemmed Lower neutrophil-to-lymphocyte ratio predicts high risk of multidrug-resistant Pseudomonas aeruginosa infection in patients with hospital-acquired pneumonia
title_short Lower neutrophil-to-lymphocyte ratio predicts high risk of multidrug-resistant Pseudomonas aeruginosa infection in patients with hospital-acquired pneumonia
title_sort lower neutrophil to lymphocyte ratio predicts high risk of multidrug resistant pseudomonas aeruginosa infection in patients with hospital acquired pneumonia
topic risk factors
prognosis
multidrug-resistant pseudomonas aeruginosa
hospital-acquired pneumonia
url https://www.dovepress.com/lower-neutrophil-to-lymphocyte-ratio-predicts-high-risk-of-multidrug-r-peer-reviewed-article-TCRM
work_keys_str_mv AT zhouyq lowerneutrophiltolymphocyteratiopredictshighriskofmultidrugresistantpseudomonasaeruginosainfectioninpatientswithhospitalacquiredpneumonia
AT fengdy lowerneutrophiltolymphocyteratiopredictshighriskofmultidrugresistantpseudomonasaeruginosainfectioninpatientswithhospitalacquiredpneumonia
AT liwj lowerneutrophiltolymphocyteratiopredictshighriskofmultidrugresistantpseudomonasaeruginosainfectioninpatientswithhospitalacquiredpneumonia
AT yanghl lowerneutrophiltolymphocyteratiopredictshighriskofmultidrugresistantpseudomonasaeruginosainfectioninpatientswithhospitalacquiredpneumonia
AT wangzn lowerneutrophiltolymphocyteratiopredictshighriskofmultidrugresistantpseudomonasaeruginosainfectioninpatientswithhospitalacquiredpneumonia
AT zhangtt lowerneutrophiltolymphocyteratiopredictshighriskofmultidrugresistantpseudomonasaeruginosainfectioninpatientswithhospitalacquiredpneumonia
AT chenzg lowerneutrophiltolymphocyteratiopredictshighriskofmultidrugresistantpseudomonasaeruginosainfectioninpatientswithhospitalacquiredpneumonia